Galectin-3 Inhibitors

Galecto Biotech has developed ultra potent galectin-3 inhibitors that specifically block the binding of galectin-3 to carbohydrate structures. The inhibitors have been shown to block various biological actions of galectin-3, which include modulation of immune processes and pro-fibrotic activity.

subpage_image_3

Broad therapeutic potential

Galectin-3 is known to play a key role in many pathological processes, rendering it an optimal drug target. Galectin-3 inhibitors has the potential to treat a range of debilitating diseases, and the company is actively pursuing several indications.